12. Earnings per Share
|
Year ended December 31 |
|
|---|---|---|
|
2025 |
2024 |
Net profit attributable to owners of the parent |
320,884 |
74,082 |
|
|
|
Number of shares (thousands) |
|
|
Weighted average number of shares for the purpose of basic earnings/loss (-) per share |
65,897 |
65,897 |
|
|
|
Basic earnings per share (€) |
4.87 |
1.12 |
|
|
|
Net profit attributable to owners of the parent |
320,884 |
74,082 |
|
|
|
Number of shares (thousands) |
|
|
Weighted average number of shares for the purpose of diluted earnings/loss (-) per share |
65,897 |
65,897 |
Number of dilutive potential ordinary shares |
4 |
45 |
|
|
|
Diluted earnings per share (in €) |
4.87 |
1.12 |
Reference is also made to note 2 where an explanation is provided about the terms and conditions of the outstanding subsequent Gilead Warrant B that can, potentially, be exercised by Gilead and lead to a dilutive effect. Due to the exercise price mechanism of the Gilead subsequent Warrant B, this warrant was out-of-the-money for 2025 and 2024.